Search

Noble E. Jarrell

Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )

Most Active Art Unit
1699
Art Unit(s)
1625, 1699, 1622, 1624, 1609
Total Applications
1419
Issued Applications
950
Pending Applications
180
Abandoned Applications
334

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19142132 [patent_doc_number] => 20240140956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => Novel Pharmaceutical Intermediates and Methods for Preparing the Same [patent_app_type] => utility [patent_app_number] => 18/521224 [patent_app_country] => US [patent_app_date] => 2023-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4223 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18521224 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/521224
Novel Pharmaceutical Intermediates and Methods for Preparing the Same Nov 27, 2023 Pending
Array ( [id] => 19411714 [patent_doc_number] => 12077519 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-03 [patent_title] => Heteroaryl carboxamide compound [patent_app_type] => utility [patent_app_number] => 18/521400 [patent_app_country] => US [patent_app_date] => 2023-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22707 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18521400 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/521400
Heteroaryl carboxamide compound Nov 27, 2023 Issued
Array ( [id] => 19097707 [patent_doc_number] => 20240116935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => DIACYLGLYCEROL KINASE (DGK) ALPHA INHIBITORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/507595 [patent_app_country] => US [patent_app_date] => 2023-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27230 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507595 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/507595
Diacylglycerol kinase (DGK) alpha inhibitors and uses thereof Nov 12, 2023 Issued
Array ( [id] => 19027252 [patent_doc_number] => 11926599 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-03-12 [patent_title] => 1-(2-chlorobenzylideneamino)-5,5-diphenylimidazolidine-2,4-dione as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/382819 [patent_app_country] => US [patent_app_date] => 2023-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3981 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18382819 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/382819
1-(2-chlorobenzylideneamino)-5,5-diphenylimidazolidine-2,4-dione as an antimicrobial compound Oct 22, 2023 Issued
Array ( [id] => 19210653 [patent_doc_number] => 11999701 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-06-04 [patent_title] => 4,5-bis(4-chlorophenyl)-2-phenyl-1H-imidazol-1-yl as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/382972 [patent_app_country] => US [patent_app_date] => 2023-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4210 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18382972 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/382972
4,5-bis(4-chlorophenyl)-2-phenyl-1H-imidazol-1-yl as an antimicrobial compound Oct 22, 2023 Issued
Array ( [id] => 19021304 [patent_doc_number] => 20240077475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING [patent_app_type] => utility [patent_app_number] => 18/489653 [patent_app_country] => US [patent_app_date] => 2023-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18489653 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/489653
PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING Oct 17, 2023 Pending
Array ( [id] => 18964100 [patent_doc_number] => 11897850 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-02-13 [patent_title] => N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-4-methoxybenzimidamide as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/484734 [patent_app_country] => US [patent_app_date] => 2023-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3893 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18484734 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/484734
N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-4-methoxybenzimidamide as an antimicrobial compound Oct 10, 2023 Issued
Array ( [id] => 20187055 [patent_doc_number] => 12398160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-26 [patent_title] => Cot modulators and methods of use thereof [patent_app_type] => utility [patent_app_number] => 18/374108 [patent_app_country] => US [patent_app_date] => 2023-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 24264 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18374108 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/374108
Cot modulators and methods of use thereof Sep 27, 2023 Issued
Array ( [id] => 18861795 [patent_doc_number] => 20230416230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => HIERARCHICAL NANOPOROUS DIAMONDOID SUPERSTRUCTURE [patent_app_type] => utility [patent_app_number] => 18/465749 [patent_app_country] => US [patent_app_date] => 2023-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11646 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18465749 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/465749
HIERARCHICAL NANOPOROUS DIAMONDOID SUPERSTRUCTURE Sep 11, 2023 Pending
Array ( [id] => 18842611 [patent_doc_number] => 20230405015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => SUBSTITUTED 3,6-DIHYDRO-2H-1,3,4-OXADIAZIN-2-ONES FOR THE TREATMENT OF SARCOMA [patent_app_type] => utility [patent_app_number] => 18/241186 [patent_app_country] => US [patent_app_date] => 2023-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19816 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18241186 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/241186
SUBSTITUTED 3,6-DIHYDRO-2H-1,3,4-OXADIAZIN-2-ONES FOR THE TREATMENT OF SARCOMA Aug 30, 2023 Pending
Array ( [id] => 18806990 [patent_doc_number] => 20230381323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => RELEASABLE CONJUGATES [patent_app_type] => utility [patent_app_number] => 18/234142 [patent_app_country] => US [patent_app_date] => 2023-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48481 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 319 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18234142 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/234142
RELEASABLE CONJUGATES Aug 14, 2023 Pending
Array ( [id] => 20356186 [patent_doc_number] => 12472165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-18 [patent_title] => Riluzole prodrugs and their use [patent_app_type] => utility [patent_app_number] => 18/361838 [patent_app_country] => US [patent_app_date] => 2023-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 38606 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361838 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/361838
Riluzole prodrugs and their use Jul 28, 2023 Issued
Array ( [id] => 18806816 [patent_doc_number] => 20230381149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => RILUZOLE PRODRUGS AND THEIR USE [patent_app_type] => utility [patent_app_number] => 18/361837 [patent_app_country] => US [patent_app_date] => 2023-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41341 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361837 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/361837
Riluzole prodrugs and their use Jul 28, 2023 Issued
Array ( [id] => 18987765 [patent_doc_number] => 20240059734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => MITOCHONDRIA-TARGETING PEPTIDES [patent_app_type] => utility [patent_app_number] => 18/221140 [patent_app_country] => US [patent_app_date] => 2023-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41369 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18221140 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/221140
MITOCHONDRIA-TARGETING PEPTIDES Jul 11, 2023 Pending
Array ( [id] => 18674979 [patent_doc_number] => 20230312502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => METHODS TO PURIFY CANNABINOIDS [patent_app_type] => utility [patent_app_number] => 18/328547 [patent_app_country] => US [patent_app_date] => 2023-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7106 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18328547 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/328547
METHODS TO PURIFY CANNABINOIDS Jun 1, 2023 Pending
Array ( [id] => 19065600 [patent_doc_number] => 20240100026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH [patent_app_type] => utility [patent_app_number] => 18/196106 [patent_app_country] => US [patent_app_date] => 2023-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35757 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18196106 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/196106
INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH May 10, 2023 Abandoned
Array ( [id] => 19050783 [patent_doc_number] => 20240092752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => GAS PHASE METHODS TO DECARBOXYLATE CANNABINOIDS [patent_app_type] => utility [patent_app_number] => 18/309646 [patent_app_country] => US [patent_app_date] => 2023-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18309646 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/309646
GAS PHASE METHODS TO DECARBOXYLATE CANNABINOIDS Apr 27, 2023 Pending
Array ( [id] => 19172424 [patent_doc_number] => 20240158398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE [patent_app_type] => utility [patent_app_number] => 18/137228 [patent_app_country] => US [patent_app_date] => 2023-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 104345 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18137228 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/137228
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE Apr 19, 2023 Pending
Array ( [id] => 18537438 [patent_doc_number] => 20230242530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => 8-(AZETIDIN-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/297546 [patent_app_country] => US [patent_app_date] => 2023-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28662 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18297546 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/297546
8-(AZETIDIN-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF Apr 6, 2023 Pending
Array ( [id] => 18524289 [patent_doc_number] => 20230234946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/296018 [patent_app_country] => US [patent_app_date] => 2023-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296018 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/296018
COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME Apr 4, 2023 Pending
Menu